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Available online 16 July 2009Chang Guangqi et al. report an impressive cohort of 121
consecutive patients undergoing endovascular repair of
Stanford type B aortic dissection over a 6-year period. They
confirm the favourable early outcomes reported by Mike
Dake and Christopher Nienaber in 1999 in the New England
Journal of Medicine.
This is an important report, because there is a current
desire among cardiovascular medical and surgical special-
ists to define a treatment paradigm for the treatment of
type B dissections comparable to the consensus obtained
for type A dissections. There are still many areas of
uncertainty regarding the benefit of and the indications for
endovascular treatment in this potentially devastating
pathology. In response, a number of trials and registries
have been established. Nevertheless, in addition to these
multicentre data, there is much to be learned from single-
centre experiences such as the department of vascular
surgery at theHospital of Sun Yat-senUniversity (Guangzhou,
China). However, to use these data, there is an urgent
need for consensus regarding the ‘reporting standards for
medical, surgical and endovascular treatments inDOI of original article: 10.1016/j.ejvs.2009.04.015.
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doi:10.1016/j.ejvs.2009.06.014the setting of type B dissection’. For example, how do we
define flow from the left subclavian artery (LSA) into the
false lumen despite an endograft apparently providing an
adequate proximal seal in the arch? Is it a proximal type
1 endoleak? Is a false lumen thrombosed at the level of
the endograft but patent below it (at the level of the visceral
aorta) considered a successful treatment or a failure?
I agree with the author’s statement: ‘‘Differences in
clinical statusappear tohavegreater impactonoutcomethan
the phase during which treatment was implemented.’’ In the
literature, patients presenting with malperfusion syndrome
(especially visceral malperfusion) and/or aortic rupture have
ahigh riskofdeath. Iwas therefore surprisedby the low(1.4%)
earlymortality rate in theacutedissectiongroup,despite 21%
of these patients presenting with preoperative malperfusion
syndromes. In our experience, such patients often require
dialysis, bowel resection and prolonged intensive care unit
stays. Once again, I believe that ‘standards for reporting type
B aortic dissection repair’ are mandatory if we are to be able
to measure the effectiveness of treatment strategies, based
on similar clinical presentations.
In our experience, occlusion of the LSA origin by the
endovascular device is frequently required because of
proximal primary entry tears involving the ostium of this
artery. We generally add a carotid to LSA bypass or LSAd by Elsevier Ltd. All rights reserved.
428 S. Haulontransposition in addition to a proximal LSA ligation to avoid
retrograde feeding of the aortic dissection false lumen and
also to decrease the stroke and paraplegia rates. In this
report however, there were no instances of spinal cord
ischaemia. As stated by the authors, this probably relates
to a practice of covering short lengths of aorta. Despite this
practice, they report a case of cerebellar infarction and
intend changing their practice to more extensive aortic
coverage in the future (to promote more false-lumen
thrombosis). In my opinion, they might wish to reconsider
their current position regarding coverage of the LSA without
concomitant LSA re-vascularisation.
Promoting false-lumen thrombosis is a challenging task.
It seems to be achievable in acute settings, when the
dissection flap is still very mobile. Redirection of the aortic
flow towards the true lumen by occluding the primary entry
tear with an endograft is frequently not sufficient to
completely exclude the false lumen and achieve
a complete aortic remodelling. Coverage of all dissection
tears is therefore mandatory, thus careful assessment of
the preoperative multi-slice computed tomography (CT)
scan on a three-dimensional (3D) workstation is essential to
have a precise understanding of each patient’s anatomy of
the dissection. This often requires extensive thoracic aorticcoverage, but is self-evidently not possible at the level of
the visceral aorta. Regrettably, endothelial tears at this
level are common, as is variable perfusion of critical
visceral vessels by the true and false lumens. The implan-
tation of an uncovered self-expandable stent at this level
(in addition to a proximal endograft) is currently evaluated.
In the setting of a chronic dissection, the challenge is even
greater because of the absence of mobility of the dissection
flap.
In addition to the clinical status, we need to have
precise information regarding the extent of the dissection
(length of the aorta and its branches) and the position of
the flap tears to accurately evaluate the precise role of the
various endovascular treatments in each different
anatomical circumstance. A standardised anatomic evalu-
ation with 3D workstations is required. We also need more
long-term information, in particular, regarding the evolu-
tion of patent false lumen. In summary, we need to know
precisely who we are treating, and who we should treat! We
also need to validate the current theoretical indications to
treat acute uncomplicated type B dissections reported in
the literature: false lumen diameter >22 mm, aortic
diameter >40 mm, large primary entry tear with dwarf true
lumen and rapid aortic expansion.
